aThis table summarizes data presented in Tables 4 and 5 and Text S1's table 1. Along the top row in this table, we show every type of efficacy analysis described in the protocols, SAPs, and publicatio
Data are reported as mean ± standard deviation or number (percent) or median [1st, 3rd quartile].*Data available for n = 63.Baseline characteristics in patients with type 2 diabetes (n = 82).